Molecular & Cellular Oncology
Volume 9, 2022 - Issue 1
Author’s Views
Resistance to kinase inhibition through shortened target engagement
Aziz M. Rangwalaa Department of Pharmacological Sciences, Stony Brook University Renaissance School of Medicine, Stony Brook, NY, USACorrespondence[email protected]
https://orcid.org/0000-0003-3556-7931View further author information
https://orcid.org/0000-0003-3556-7931View further author information, Benedict-Tilman Bergerb Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt am Main, Germany;c Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt am Main, Germanyhttps://orcid.org/0000-0002-3314-2617View further author information
https://orcid.org/0000-0002-3314-2617View further author information, Matthew B. Robersd Research and Development Department, Promega Corporation, Fitchburg, WI, USAhttps://orcid.org/0000-0001-8505-5227View further author information
https://orcid.org/0000-0001-8505-5227View further author information, Stefan Knappb Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt am Main, Germany;c Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt am Main, Germanyhttps://orcid.org/0000-0001-5995-6494View further author information
https://orcid.org/0000-0001-5995-6494View further author information & Markus A. Seeligera Department of Pharmacological Sciences, Stony Brook University Renaissance School of Medicine, Stony Brook, NY, USACorrespondence[email protected]
https://orcid.org/0000-0003-0990-1756View further author information
https://orcid.org/0000-0003-0990-1756View further author information